Sarda Proteins Ltd
₹ 88.7
5.00%
11 May
- close price
- Market Cap ₹ 79.6 Cr.
- Current Price ₹ 88.7
- High / Low ₹ 144 / 60.0
- Stock P/E 124
- Book Value ₹ 2.54
- Dividend Yield 0.00 %
- ROCE 27.0 %
- ROE 27.0 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company's working capital requirements have reduced from 229 days to 50.8 days
Cons
- Stock is trading at 34.9 times its book value
- Company has a low return on equity of 9.44% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.02 | 2.06 | 6.18 | 5.65 | 7.22 | 5.40 | 11.36 | 10.76 | 5.80 | 1.30 | 24.19 | 16.16 | |
| 5.14 | 2.18 | 6.35 | 6.00 | 7.33 | 5.31 | 11.38 | 10.50 | 5.95 | 1.45 | 24.17 | 15.87 | |
| Operating Profit | -0.12 | -0.12 | -0.17 | -0.35 | -0.11 | 0.09 | -0.02 | 0.26 | -0.15 | -0.15 | 0.02 | 0.29 |
| OPM % | -2.39% | -5.83% | -2.75% | -6.19% | -1.52% | 1.67% | -0.18% | 2.42% | -2.59% | -11.54% | 0.08% | 1.79% |
| 0.80 | 0.00 | 0.00 | -0.01 | 0.03 | 0.08 | 0.08 | 0.09 | 0.16 | 0.17 | 0.00 | 0.35 | |
| Interest | 0.02 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.04 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.62 | -0.17 | -0.19 | -0.37 | -0.09 | 0.17 | 0.06 | 0.35 | 0.01 | 0.02 | 0.02 | 0.64 |
| Tax % | 4.84% | -5.88% | -31.58% | -10.81% | 44.44% | 82.35% | 133.33% | 14.29% | 500.00% | 0.00% | 100.00% | 0.00% |
| 0.59 | -0.15 | -0.13 | -0.33 | -0.12 | 0.03 | -0.02 | 0.31 | -0.03 | 0.02 | 0.01 | 0.64 | |
| EPS in Rs | 1.80 | -0.87 | -0.75 | -1.91 | -0.70 | 0.17 | -0.12 | 1.80 | -0.17 | 0.12 | 0.06 | 0.71 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 7% |
| 3 Years: | 41% |
| TTM: | -33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 102% |
| 3 Years: | 186% |
| TTM: | 6300% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 29% |
| 3 Years: | 21% |
| 1 Year: | -32% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 8% |
| 3 Years: | 9% |
| Last Year: | 27% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.43 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 |
| Reserves | 0.30 | 0.15 | 0.02 | -0.31 | -0.44 | -0.41 | -0.43 | -0.12 | -0.15 | -0.13 | -0.13 | -0.22 |
| 0.21 | 0.61 | 0.20 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | |
| 0.20 | 0.21 | 0.20 | 0.13 | 0.12 | 0.06 | 0.07 | 0.07 | 0.05 | 0.07 | 0.28 | 84.69 | |
| Total Liabilities | 3.14 | 3.47 | 2.92 | 2.32 | 2.19 | 2.15 | 2.14 | 2.45 | 2.40 | 2.44 | 2.65 | 87.13 |
| 0.10 | 0.06 | 0.05 | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 3.03 | 3.40 | 2.86 | 2.28 | 2.17 | 2.14 | 2.13 | 2.45 | 2.40 | 2.44 | 2.65 | 87.13 | |
| Total Assets | 3.14 | 3.47 | 2.92 | 2.32 | 2.19 | 2.15 | 2.14 | 2.45 | 2.40 | 2.44 | 2.65 | 87.13 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.72 | -1.20 | -0.09 | 0.48 | -0.59 | -0.05 | -0.05 | 0.10 | -0.30 | -0.23 | -0.11 | -76.39 | |
| 1.90 | 0.20 | 0.00 | 0.02 | 0.11 | 0.09 | 0.08 | 0.09 | 0.16 | 0.17 | 0.00 | 0.36 | |
| -0.13 | 0.37 | -0.42 | -0.20 | 0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 83.51 | |
| Net Cash Flow | 1.05 | -0.63 | -0.51 | 0.30 | -0.47 | 0.03 | 0.03 | 0.19 | -0.14 | -0.07 | -0.08 | 7.48 |
| Free Cash Flow | 0.73 | -1.18 | -0.09 | 0.48 | -0.59 | -0.04 | -0.05 | 0.10 | -0.30 | -0.23 | -0.11 | -76.38 |
| CFO/OP | 525% | 1,000% | 53% | -134% | 536% | -22% | 200% | 38% | 200% | 153% | -550% | -26,341% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 13.81 | 0.00 | 38.98 | 44.58 | 36.40 | 56.10 | 24.74 | 7.12 | 0.00 | 0.00 | 0.00 | |
| Inventory Days | 32.70 | 324.22 | 64.41 | 28.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Days Payable | 0.76 | 0.00 | 0.61 | 0.00 | ||||||||
| Cash Conversion Cycle | 45.75 | 324.22 | 102.78 | 73.22 | 36.40 | 56.10 | 24.74 | 7.12 | 0.00 | 0.00 | 0.00 | |
| Working Capital Days | 65.44 | 251.60 | 108.08 | 76.23 | 83.92 | 114.91 | 55.91 | 64.45 | 130.27 | 603.65 | 33.95 | |
| ROCE % | -5.93% | -4.52% | -6.02% | -14.66% | -5.63% | 8.17% | 2.88% | 15.73% | 0.42% | 0.85% | 0.84% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mustard Oil Sales Revenue INR Lakhs |
|
||||||||||
| Mustard Seed / RM Seed Sales Revenue INR Lakhs |
|||||||||||
| Number of Permanent Employees Number |
|||||||||||
| Solar Cell Sales Revenue INR Lakhs |
|||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Outcome for Results - March 2026
30 Apr - Board approved audited FY26 results; profit rose to Rs 63.79 lakh, unmodified audit opinion.
-
Board Meeting Intimation for Meeting Of The Board Of The Company Is Scheduled To Be Held On Thursday, 30Th April, 2026 To Consider And Approve Standalone Audited Financial Results For The Quarter And Year Ended 31St March 2026
28 Apr - Board to meet on 30 April 2026 to approve standalone audited FY26 results; trading window closed since 1 April.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Apr - Submitted RTA certificate for dematerialised/rematerialized securities for quarter ended March 31, 2026.
-
Draft Letter of Offer
8 Apr - Grow House Wealth Management Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders …
-
Closure of Trading Window
31 Mar - Trading window closed from 1 Apr 2026 until 48 hours after audited results for quarter/year ended 31 Mar 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2][3]
a) SPL used to deal in the protein products
and various other food products.
b) However, on 4th Sept 2024, the company resolved to switch its business to Power Industry for solar cell manufacturing and to deal
into dealing with all the machinery, instruments, and equipment for solar cell manufacturing
and solar power generation.
c) Hence, the company changed and
added a business objective to deal with
the renewable energy sector and solar
cell products.
d) Currently, it has core expertise in solar plant services, carbon-credit markets, intelligent asset management, and advanced automation technologies.